JOHN W. KOZARICH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LIGAND PHARMACEUTICALS INC

Filing Date Source Excerpt
2014-04-21 John W. Kozarich(N) Chairman of the Board 2003 64 ... The nominating and corporate governance committee currently consists of Mr. Aryeh (chair) and Drs. Kozarich and Sabba. ... The following table provides information related to the compensation of each of our non-employee directors for fiscal 2013. ... John W. Kozarich(4) 69,000 94,478 149,647 — 313,125 ... (4) As of December 31, 2013, Dr. Kozarich held options to purchase 37,039 shares of our common stock and 2,925 unvested shares of restricted stock. During 2013, Dr. Kozarich received 2,925 restricted stock units with a grant date fair value of $94,478 and 7,335 stock options with a grant date fair value of $149,647. Dr. Kozarich elected to receive 1,393 shares of fully vested stock in lieu of $45,000 of his 2013 cash retainer for his services as a non-employee director.
2015-03-13 John W. Kozarich(N) - Chairman of the Board, Age 65, Member of the nominating and corporate governance committee (N). Compensation: $297,659 in 2014.
2016-04-12 John W. Kozarich(N) Chairman of the Board 66 2003 (A) Member of the audit committee (N) Member of the nominating and corporate governance committee ... The audit committee currently consists of Messrs. Knott and Patel and Dr. Sabba (chair). Our board of directors will appoint one of our remaining independent directors to the audit committee on or prior to the 2016 annual meeting to replace Mr. Knott. ... The nominating and corporate governance committee currently consists of Mr. Aryeh (chair) and Drs. Kozarich and Sabba. ... Compensation of Directors ... John W. Kozarich(4) As of December 31, 2015, Dr. Kozarich held options to purchase 33,903 shares of our common stock and 925 restricted stock units. During 2015, Dr. Kozarich received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. ... Cash Fees $80,064 Stock Awards $83,019 Option Awards $139,946 Total $303,029
2017-04-14 John W. Kozarich(N) Chairman of the Board 2003 67 ... The audit committee currently consists of Messrs. Davis and Patel and Dr. Sabba (chair). ... The nominating and corporate governance committee currently consists of Mr. Aryeh (chair) and Drs. Kozarich and Sabba. ... The following table provides information related to the compensation of each of our non-employee directors for fiscal 2016. ... John W. Kozarich 81,509 74,205 140,557 296,271 ... During 2016, Dr. Kozarich received 622 restricted stock units with a grant date fair value of $74,205 and 2,329 stock options with a grant date fair value of $140,557.
2020-11-12 The following table provides information related to the compensation of each of our non-employee directors for fiscal 2019. John W. Kozarich Cash Fees $85,027, Stock Awards $94,848, Option Awards $190,025, Total $369,900

Data sourced from SEC filings. Last updated: 2026-02-03